Mark Biffen

609 total citations
24 papers, 525 citations indexed

About

Mark Biffen is a scholar working on Immunology, Molecular Biology and Physiology. According to data from OpenAlex, Mark Biffen has authored 24 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 7 papers in Molecular Biology and 6 papers in Physiology. Recurrent topics in Mark Biffen's work include Immune Cell Function and Interaction (9 papers), Immune Response and Inflammation (8 papers) and Asthma and respiratory diseases (5 papers). Mark Biffen is often cited by papers focused on Immune Cell Function and Interaction (9 papers), Immune Response and Inflammation (8 papers) and Asthma and respiratory diseases (5 papers). Mark Biffen collaborates with scholars based in United Kingdom, Slovakia and Japan. Mark Biffen's co-authors include Denis R. Alexander, Masahiro Shiroo, Lindsey K. Goff, David E. Hanke, Bronwen Martin, Ashok R. Venkitaraman, Thomas R. Larson, Baptiste Martin, Clare Murray and Hiroyuki Matsui and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and The Journal of Immunology.

In The Last Decade

Mark Biffen

24 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Biffen United Kingdom 13 299 229 77 62 57 24 525
Gregory Deno United States 12 311 1.0× 179 0.8× 62 0.8× 255 4.1× 46 0.8× 13 597
Julia Tseng United States 7 230 0.8× 230 1.0× 74 1.0× 149 2.4× 49 0.9× 7 506
Gretchen N. Schwartz United States 15 237 0.8× 210 0.9× 27 0.4× 172 2.8× 24 0.4× 33 616
Hideo Yagita Japan 8 365 1.2× 174 0.8× 34 0.4× 80 1.3× 57 1.0× 8 551
Ursula Protin Germany 5 92 0.3× 190 0.8× 89 1.2× 71 1.1× 46 0.8× 11 452
Neeraj Tiwari France 9 367 1.2× 213 0.9× 85 1.1× 24 0.4× 113 2.0× 9 538
Paola Bet Italy 8 170 0.6× 249 1.1× 44 0.6× 27 0.4× 24 0.4× 9 497
H.N. Fernández Argentina 9 161 0.5× 158 0.7× 48 0.6× 27 0.4× 23 0.4× 13 383
Akie Maehara Japan 11 278 0.9× 164 0.7× 66 0.9× 70 1.1× 62 1.1× 18 492
Sandeep K. Raghuwanshi United States 11 315 1.1× 283 1.2× 43 0.6× 276 4.5× 79 1.4× 12 648

Countries citing papers authored by Mark Biffen

Since Specialization
Citations

This map shows the geographic impact of Mark Biffen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Biffen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Biffen more than expected).

Fields of papers citing papers by Mark Biffen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Biffen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Biffen. The network helps show where Mark Biffen may publish in the future.

Co-authorship network of co-authors of Mark Biffen

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Biffen. A scholar is included among the top collaborators of Mark Biffen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Biffen. Mark Biffen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Delaney, Stephen, Mark Biffen, John Bell, et al.. (2016). Tolerability in man following inhalation dosing of the selective TLR7 agonist, AZD8848. BMJ Open Respiratory Research. 3(1). e000113–e000113. 18 indexed citations
3.
Matsui, Hiroyuki, Hideyuki Tomizawa, Yasuo Kashiwazaki, et al.. (2012). Mechanism of Action of Inhibition of Allergic Immune Responses by a Novel Antedrug TLR7 Agonist. The Journal of Immunology. 189(11). 5194–5205. 16 indexed citations
4.
Biffen, Mark, Hiroyuki Matsui, Andrew J. Leishman, et al.. (2011). Biological characterization of a novel class of toll‐like receptor 7 agonists designed to have reduced systemic activity. British Journal of Pharmacology. 166(2). 573–586. 30 indexed citations
5.
Biffen, Mark, Hiroyuki Matsui, Ian Doyle, et al.. (2010). Biological Activity Of Novel TLR7 Ante-drug Agonists For The Treatment Of Allergic Diseases. A4265–A4265. 2 indexed citations
6.
Matsui, Hiroyuki, Hideyuki Tomizawa, Mark Biffen, et al.. (2010). Mechanisms Of Inhibition Of Type-2 Cytokines By Novel Ante-drug TLR7 Agonists. A4041–A4041. 2 indexed citations
7.
Biffen, Mark, Bob Thong, Peter Calverley, et al.. (2007). Haemophilus influenzae Induces Neutrophil Necrosis. American Journal of Respiratory Cell and Molecular Biology. 37(2). 135–143. 37 indexed citations
8.
Walker, Craig S., et al.. (2002). Purification and characterization of recombinant rat mast cell protease 7 expressed in Pichia pastoris. Protein Expression and Purification. 25(2). 256–262. 4 indexed citations
10.
Biffen, Mark & Denis R. Alexander. (1994). Mobilization of intracellular Ca2+ by adenine nucleotides in human T-leukaemia cells: evidence for ADP-specific and P2y-purinergic receptors. Biochemical Journal. 304(3). 769–774. 15 indexed citations
11.
Biffen, Mark, Masahiro Shiroo, & Denis R. Alexander. (1993). Selective coupling of the T cell antigen receptor to phosphoinositide‐derived diacylglycerol production in HPB‐ALL T cells correlates with CD45‐regulated p59fyn activity. European Journal of Immunology. 23(11). 2980–2987. 7 indexed citations
12.
Biffen, Mark, Masahiro Shiroo, & Denis R. Alexander. (1993). G-proteins are not directly involved in the CD3-antigen-mediated production of inositol phosphates in HPB-ALL T-leukaemia cells expressing phospholipase C isoforms γ1 and β3. Biochemical Journal. 289(2). 387–394. 5 indexed citations
13.
Alexander, Denis R., et al.. (1992). The role of CD45 in T-cell activation — resolving the paradoxes?. Immunology Today. 13(12). 477–481. 44 indexed citations
14.
Biffen, Mark, et al.. (1992). Does co‐aggregation of the CD45 and CD3 antigens inhibit T cell antigen receptor complex‐mediated activation of phospholipase C and protein kinase C?. European Journal of Immunology. 22(4). 1055–1062. 18 indexed citations
16.
Biffen, Mark & David E. Hanke. (1991). Metabolic fate of myo-inositol in soybean callus cells. Plant Science. 75(2). 203–213. 8 indexed citations
17.
Biffen, Mark & David E. Hanke. (1990). Reduction in the level of intracellular myo-inositol in cultured soybean (Glycine max) cells inhibits cell division. Biochemical Journal. 265(3). 809–814. 14 indexed citations
18.
Biffen, Mark, et al.. (1990). Phosphoinositides and plant growth substance action.. PubMed. 44. 193–205. 5 indexed citations
19.
Biffen, Mark & Bronwen Martin. (1989). Inhibition of PI-kinase in rat liver membranes by F−. Cellular Signalling. 1(3). 283–287. 3 indexed citations
20.
Biffen, Mark & Baptiste Martin. (1987). Polyphosphoinositide labeling in rat liver plasma membranes is reduced by preincubation with cholera toxin.. Journal of Biological Chemistry. 262(16). 7744–7750. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026